Product NDC: | 12496-0757 |
Proprietary Name: | Buprenex |
Non Proprietary Name: | Buprenorphine Hydrochloride |
Active Ingredient(s): | .3 mg/mL & nbsp; Buprenorphine Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 12496-0757 |
Labeler Name: | Reckitt Benckiser Pharmaceuticals Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018401 |
Marketing Category: | NDA |
Start Marketing Date: | 19850630 |
Package NDC: | 12496-0757-1 |
Package Description: | 5 AMPULE in 1 CARTON (12496-0757-1) > 1 mL in 1 AMPULE |
NDC Code | 12496-0757-1 |
Proprietary Name | Buprenex |
Package Description | 5 AMPULE in 1 CARTON (12496-0757-1) > 1 mL in 1 AMPULE |
Product NDC | 12496-0757 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Buprenorphine Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19850630 |
Marketing Category Name | NDA |
Labeler Name | Reckitt Benckiser Pharmaceuticals Inc |
Substance Name | BUPRENORPHINE HYDROCHLORIDE |
Strength Number | .3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA] |